Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

INBX

Inhibrx Biosciences Inc

May 22 • 04:00PM ET

101.32

-9.25 -8.37 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NRIX ARVN KYMR BCYC IDYA

| Held by: VTI XBI IWM VXF IWN IBB FYC VTWO FYX KOMP

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-8.39	Insider Own	29.89%	Shs Outstand	14.61M	Perf Week	-6.74%
Market Cap	1.49B	Forward P/E	-	EPS next Y	-6.53	Insider Trans	0.00%	Shs Float	12.01M	Perf Month	-15.52%
Enterprise Value	1.51B	PEG	-	EPS next Q	-2.28	Inst Own	77.00%	Short Float	22.76%	Perf Quarter	32.29%
Income	-130.19M	P/S	1143.45	EPS this Y	-2.16%	Inst Trans	1.89%	Short Ratio	6.93	Perf Half Y	23.35%
Sales	1.30M	P/B	-	EPS next Y	29.29%	ROA	-61.03%	Short Interest	2.73M	Perf YTD	28.25%
Book/sh	-1.44	P/C	9.20	EPS next 5Y	23.96%	ROE	-354.69%	52W High	155.29 -34.75%	Perf Year	707.97%
Cash/sh	11.02	P/FCF	-	EPS past 3/5Y	3.40% -	ROIC	-82.68%	52W Low	12.24 727.44%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-15.98% -	Gross Margin	-80.38%	Volatility	9.45% 10.66%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1158.25	EPS Y/Y TTM	-107.04%	Oper. Margin	-9465.46%	ATR (14)	11.93	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.46	Sales Y/Y TTM	550.00%	Profit Margin	-10014.23%	RSI (14)	44.50	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	6.46	EPS Q/Q	23.37%	SMA20	-16.19%	Beta	3.67	Target Price	277.50
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	8.10%	Rel Volume	1.40	Prev Close	110.57
Employees	110	LT Debt/Eq	-	Earnings	May 14 AMC	SMA200	47.48%	Avg Volume	394.64K	Price	101.32
IPO	May 29, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.36% -	Trades		Volume	552,879	Change	-8.37%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)